Russell Investments Group’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Russell Investments Group’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$34.7K	Sell	140 -62	-31%	-$13.4K	﹤0.01%	3703
2026 Q1	$40.6K	Buy	202 +42	+26%	+$8.69K	﹤0.01%	3392
2025 Q4	$33K	Hold	160	–	–	﹤0.01%	3451
2025 Q3	$28.7K	Buy	160 +158	+7,900%	+$26.9K	﹤0.01%	3481
2025 Q2	$323	Hold	2	–	–	﹤0.01%	3774
2025 Q1	$340	Sell	2 -4	-67%	-$695	﹤0.01%	3707
2024 Q4	$997	Sell	6 -5	-45%	-$854	﹤0.01%	3529
2024 Q3	$1.89K	Buy	+11	New	+$1.82K	﹤0.01%	3385

Other funds holding FBT

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $72.7B AUM 39.36% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.96B AUM 20.58% 1-Year Est. Return

Russell Investments Group's FBT Position: Q2 2026 in Review

Russell Investments Group reduced its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 31% in Q2 2026, selling an estimated $13.4K and leaving 140 shares worth $34.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3703.

Russell Investments Group first reported a position in FBT in Q3 2024 and has held it in 8 quarters since. The position peaked at $40.6K in Q1 2026. 340 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

Russell Investments Group held 140 shares of First Trust NYSE Arca Biotechnology Index Fund worth $34.7K as of Q2 2026.
Russell Investments Group sold 62 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2026, an estimated $13.4K.
First Trust NYSE Arca Biotechnology Index Fund made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #3703 holding.
Russell Investments Group first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q3 2024 and has held it in 8 quarters since.
Russell Investments Group's First Trust NYSE Arca Biotechnology Index Fund position peaked at $40.6K in Q1 2026.
340 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.